Differential modulation of natural killer cell cytotoxicity by 17β-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells

被引:8
|
作者
Godoy-Pacheco, Alejandro [1 ]
Garcia-Chagollan, Mariel [2 ]
Ramirez-De-Arellano, Adrian [2 ]
Hernandez-Silva, Christian David [2 ]
Villegas-Pineda, Julio Cesar [1 ,3 ]
Ramirez-Lopez, Inocencia Guadalupe [1 ]
Zepeda-Nuno, Jose Sergio [4 ]
Aguilar-Lemarroy, Adriana [5 ]
Pereira-Suarez, Ana Laura [2 ,3 ,6 ]
机构
[1] Univ Guadalajara, Univ Ctr Hlth Sci, Dept Physiol, Guadalajara 44340, Jalisco, Mexico
[2] Univ Guadalajara, Univ Ctr Hlth Sci, Inst Res Biomed Sci, Guadalajara 44340, Jalisco, Mexico
[3] Univ Guadalajara, Univ Ctr Hlth Sci, Dept Microbiol & Pathol, Guadalajara 44340, Jalisco, Mexico
[4] Univ Guadalajara, Univ Ctr Hlth Sci, Ctr Res & Diag Pathol, Dept Microbiol & Pathol, Guadalajara 44340, Jalisco, Mexico
[5] Western Biomed Res Ctr, Dept Immunol, Guadalajara 44340, Jalisco, Mexico
[6] Univ Guadalajara, Univ Ctr Hlth Sci, Dept Microbiol & Pathol, Sierra Mojada 950,Colonia Independencia, Guadalajara 44340, Jalisco, Mexico
关键词
natural killer cells; cervical cancer; prolactin; prolactin receptor; 17; beta-estradiol; estrogen receptor; cytotoxicity; tumor microenvironment; ESTROGEN-RECEPTOR-ALPHA; I-RELATED CHAIN; NK CELLS; NKG2D EXPRESSION; RISK-FACTORS; T-CELLS; LIGANDS; PROTEIN; MECHANISMS; ESTRADIOL;
D O I
10.3892/ol.2022.13408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) cells play a crucial role in cervical cancer (CC). As estrogens and prolactin (PRL) have been reported to be involved in CC, the present study attempted to elucidate the effects of both hormones on NK cells in CC. For this purpose, NKL cells, as well as CC-derived cell lines (HeLa, SiHa and C33A) and non-tumorigenic keratinocytes (HaCaT cells) were stimulated with 17 beta-estradiol (E2; 10 nM), PRL (200 ng/ml), or both (E2 and PRL) for 48 h. The expression of hormone receptors (estrogen receptor alpha and beta, G protein-coupled estrogen receptor 1 and PRL receptor) and NK cell activating receptors [natural killer group 2D (NKG2D), natural cytotoxicity triggering receptor 3, natural cytotoxicity triggering receptor 2 and natural cytotoxicity triggering receptor 1] were measured using western blot analysis and flow cytometry, respectively. In the HeLa, SiHa, C33A and HaCaT cells stimulated with the hormones, the expression of NKG2D ligands [MHC class I polypeptide-related sequence A/B (MICA/B)] on the membrane and the soluble form of MICA was evaluated using flow cytometry and ELISA. Cytotoxicity assay was performed using GFP-transfected K562 cells as target cells. E2 reduced NKL cell-mediated cytotoxicity, while PRL exerted the opposite effect. NKL cells expressed different hormone receptor forms, of which PRL only induced a decrease in NKG2D expression compared to the untreated control NKL cells. PRL increased MICA/B expression in HeLa cells and E2 and PRL reversed this effect. However, in SiHa cells, the concurrent incubation with the two hormones decreased MICA/B expression. E2 and PRL, either alone or in combination, decreased soluble MICA secretion in all CC cell lines, while E2 solely increased soluble MICA secretion in SiHa cells. On the whole, the present study provides evidence that E2 and PRL mediate the mechanisms through which NK and CC cells mediate a cytotoxic response and these have an antagonistic effect on NK cell-mediated cytotoxicity.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Targeting NKG2D/NKG2DL axis in multiple myeloma therapy
    Liu, Zhaoyun
    Wang, Hao
    Liu, Hui
    Ding, Kai
    Shen, Hongli
    Zhao, Xianghong
    Fu, Rong
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 76 : 1 - 11
  • [2] New prospects on the NKG2D/NKG2DL system for oncology
    Ullrich, Evelyn
    Koch, Joachim
    Cerwenka, Adelheid
    Steinle, Alexander
    ONCOIMMUNOLOGY, 2013, 2 (10):
  • [3] Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
    Ding, Hui
    Yang, Xi
    Wei, Yanzhang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [4] Natural killer NKG2A and NKG2D in patients with colorectal cancer
    Meckawy, Ghada R.
    Mohamed, Ahmed M.
    Zaki, Wafaa K.
    Khattab, Mona A.
    Amin, Mariam M.
    ElDeeb, M. A.
    El-Najjar, Marwa R.
    Safwat, Nesma A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (02) : 218 - 225
  • [5] The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
    Stojanovic, Ana
    Correia, Margareta P.
    Cerwenka, Adelheid
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
    Jimenez-Perez, Miriam I.
    Jave-Suarez, Luis F.
    Ortiz-Lazareno, Pablo C.
    Bravo-Cuellar, Alejandro
    Gonzalez-Ramella, Oscar
    Aguilar-Lemarroy, Adriana
    Hernandez-Flores, Georgina
    Pereira-Suarez, Ana L.
    Daneri-Navarro, Adrian
    del Toro-Arreola, Susana
    BMC IMMUNOLOGY, 2012, 13
  • [7] Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
    Desimio, Maria G.
    Covino, Daniela A.
    Doria, Margherita
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [8] Decreased NKG2D Expression on Natural Killer Cells in Gastric Cancer Patients
    Karagoz, Buelent
    Bilgi, Oguz
    Kandemir, E. Goekhan
    Sayan, Ozkan
    Erikci, Alev A.
    Ozgun, Alpaslan
    Yilmaz, Bahiddin
    Turken, Orhan
    Ozturk, Ahmet
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (01): : 42 - 47
  • [9] Modulation of NKG2D, KIR2DL and Cytokine Production by Pleurotus ostreatus Glucan Enhances Natural Killer Cell Cytotoxicity Toward Cancer Cells
    El-Deeb, Nehal M.
    El-Adawi, Hala, I
    Abd El-wahab, Abeer E.
    Haddad, Ahmed M.
    El Enshasy, Hesham A.
    He, You-Wen
    Davis, Keith R.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [10] Romidepsin Enhances the Killing Ability of NKG2D-CAR-T Cells through Enhanced Expression of NKG2DL against Ovarian Cancer Cells
    Wang, Liang
    Lin, Xite
    Yu, Lirui
    Sun, Pengming
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (10)